These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 9330414

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
    Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA.
    Respir Med; 1996 Nov; 90(10):609-17. PubMed ID: 8959118
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL.
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [Abstract] [Full Text] [Related]

  • 66. Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial.
    Kooi EM, Schokker S, Marike Boezen H, de Vries TW, Vaessen-Verberne AA, van der Molen T, Duiverman EJ.
    Pulm Pharmacol Ther; 2008 Oct; 21(5):798-804. PubMed ID: 18647656
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
    Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ, EDICT Investigators.
    Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
    [Abstract] [Full Text] [Related]

  • 72. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma.
    van Aalderen WM, Price D, De Baets FM, Price J.
    Respir Med; 2007 Jul; 101(7):1585-93. PubMed ID: 17254760
    [Abstract] [Full Text] [Related]

  • 73. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children.
    Lyttle B, Gilles J, Panov M, Emeryk A, Wixon C.
    Can Respir J; 2003 Mar; 10(2):103-9. PubMed ID: 12687029
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.